vorinostat
Ligand Summary
A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
UNII: 58IFB293JI
PubChem: 5311
Guide to Pharmacology: 6852
ChEMBL: CHEMBL98
DrugCentral: 4124
LyCHI: 3A6WF2F4D5BG
Target Activities
985 Activities
Items per page:
10
1 – 10 of 985
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||